Quantitative Biology
at the University of Delaware
Advisory Board
-
Mission Statement
The mission of the BS in Quantitative Biology (QBIO) Advisory Board is to
provide ongoing evaluation of the appropriateness and effectiveness of the QBIO
curriculum, to offer technical expertise and assistance in the design and use of
classroom materials, and to help the faculty keep QBIO students aware of
opportunities for off-campus research and future employment.
-
Membership
- Dr. Robert E. Akins, Ph.D., FAHA, Adjunct Associate Professor of
Biological Sciences, UD; Adjunct Professor in Materials Science and Engineering, UD;
Head, Tissue Engineering and Regenerative
Medicine Research, A.I. DuPont Hospital for Children
- Dr. Bruce Boman, M.D., Ph.D., M.S.P.H., FACP, Associate Scientist,
Center for Translational Cancer Research; Director, Cancer Genetics and
Stem Cell Biology, Helen F. Graham Cancer Center ; Professor of Medical
Oncology, Thomas Jefferson University
- Dr. James Bosley, Jr., Ph.D., PE, Principal, Rosa & Co, LLC, A
Bio/Pharma Consultancy
- Dr. Anastasia Christianson (Chair), Ph.D., Sr. Director and Global Skill
Leader, Biomedical Informatics, AstraZeneca Pharmaceuticals
- Dr. Kelvin H. Lee, Gore Professor of Chemical Engineering, UD; Director,
Delaware Biotechnology Institute
- Dr. Robert Leipold, Ph.D., Senior Principal Scientist, Pfizer